In the demanding field of peptide synthesis and related biochemical research, the quality of starting materials directly dictates the success of an experiment. O-Ethyl-N-Fmoc-D-tyrosine, identified by its CAS number 162502-65-0, is a prime example of a specialty amino acid derivative whose careful selection can significantly impact research outcomes. This Fmoc-protected building block, appearing as a white to off-white powder, is indispensable for researchers aiming to construct complex peptide sequences with high fidelity.

The decision to buy O-Ethyl-N-Fmoc-D-tyrosine from trusted suppliers is a strategic one. Its role as a core component in solid-phase peptide synthesis (SPPS) necessitates a high degree of purity and consistent reactivity. A purity of u226598.0% ensures that the Fmoc-protected D-tyrosine derivative participates effectively in coupling reactions, minimizing the introduction of impurities into the final peptide product. This is particularly important in applications like drug discovery, where even minor deviations in peptide sequence or structure can lead to altered biological activity or toxicity.

Furthermore, the specific ethyl ether modification on the tyrosine side chain of O-Ethyl-N-Fmoc-D-tyrosine provides unique advantages. It can influence the conformational stability and interaction profiles of the resulting peptides, making it a valuable tool for researchers exploring structure-function relationships in proteomics. For those undertaking custom peptide synthesis, this modified amino acid allows for the design of peptides with tailored properties, opening doors to novel therapeutic agents and advanced biochemical probes.

The importance of using O-Ethyl-N-Fmoc-D-tyrosine extends to its contribution to efficient and reproducible research. By providing a reliable and well-characterized building block, it empowers scientists to focus on the intricacies of their experiments rather than troubleshooting issues related to reagent quality. Whether for fundamental biochemical studies or the development of next-generation peptide therapeutics, the careful selection and application of high-quality O-Ethyl-N-Fmoc-D-tyrosine are fundamental to achieving breakthrough results.